NLRP3 and asthma: Kim et al. demonstrated the role of CCR6+ IL-17A-producing ILC3s as well as NLRP3-IL-1β signaling in lung inflammation for the first time, through a mouse model with an HFD-induced asthma (Kim et al., 2014).